CSE-1034 versus ceftriaxone: Efficacy and safety analysis from a randomized, open-labeled phase III study in complicated urinary tract infections

CSE-1034 versus ceftriaxone: Efficacy and safety analysis from a randomized, open-labeled phase III study in complicated urinary tract infections

Objective: The aim of this study was to determine the clinical outcome, microbiological outcome and safety profile of CSE-1034, a novel combination of Ceftriaxone, Sulbactam and EDTA in patients with complicated urinary tract infections (cUTI). Materials and Methods: This was a randomized, controlle...

Full description

Bibliographic Details
Main Authors: Manu Chaudhary, Shiekh Gazalla Ayub, Mohd Amin Mir, Members of Study GroupFNx01
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Journal of Global Infectious Diseases
Subjects:
Ceftriaxone
CSE-1034
cUTI
anti-microbial resistance
Online Access:http://www.jgid.org/article.asp?issn=0974-777X;year=2018;volume=10;issue=4;spage=188;epage=195;aulast=Chaudhary

Internet

http://www.jgid.org/article.asp?issn=0974-777X;year=2018;volume=10;issue=4;spage=188;epage=195;aulast=Chaudhary

Similar Items